ATE203906T1 - Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol - Google Patents

Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol

Info

Publication number
ATE203906T1
ATE203906T1 AT97922189T AT97922189T ATE203906T1 AT E203906 T1 ATE203906 T1 AT E203906T1 AT 97922189 T AT97922189 T AT 97922189T AT 97922189 T AT97922189 T AT 97922189T AT E203906 T1 ATE203906 T1 AT E203906T1
Authority
AT
Austria
Prior art keywords
preparation
benzimidazole
piperazinyl
chloro
isopropyl
Prior art date
Application number
AT97922189T
Other languages
English (en)
Inventor
Takateru Muraoka
Keigo Inosaka
Hitoshi Akemi
Hiroko Ishitani
Saburo Otsuka
Yoshiteru Takahashi
Original Assignee
Nitto Denko Corp
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp, Akzo Nobel Nv filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of ATE203906T1 publication Critical patent/ATE203906T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT97922189T 1996-05-29 1997-05-26 Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol ATE203906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8134914A JPH09315976A (ja) 1996-05-29 1996-05-29 経皮投与用製剤
PCT/JP1997/001781 WO1997045121A1 (fr) 1996-05-29 1997-05-26 Preparation destinee a une administration percutanee

Publications (1)

Publication Number Publication Date
ATE203906T1 true ATE203906T1 (de) 2001-08-15

Family

ID=15139492

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97922189T ATE203906T1 (de) 1996-05-29 1997-05-26 Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4- methyl-1-piperazinyl)benzimidazol

Country Status (7)

Country Link
US (1) US6077528A (de)
EP (1) EP0965342B1 (de)
JP (1) JPH09315976A (de)
CN (1) CN1219874A (de)
AT (1) ATE203906T1 (de)
DE (1) DE69706070T2 (de)
WO (1) WO1997045121A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10167956A (ja) * 1996-12-11 1998-06-23 Hisamitsu Pharmaceut Co Inc セロトニン受容体拮抗薬含有経皮投与製剤
US6132761A (en) * 1997-09-05 2000-10-17 Nitto Denko Corporation Percutaneous absorption preparation
JP5334346B2 (ja) * 1999-08-10 2013-11-06 久光製薬株式会社 ロール状外用貼付剤
JP5021124B2 (ja) * 2001-08-29 2012-09-05 日東電工株式会社 医療用粘着組成物、それを用いた医療用粘着テープおよび経皮吸収用テープ製剤
JP4311728B2 (ja) * 2003-12-10 2009-08-12 ニチバン株式会社 経皮吸収型貼付剤
CA2548864C (en) * 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
ATE415153T1 (de) * 2005-06-06 2008-12-15 Nitto Denko Corp Pharmazeutische zusammensetzung zur perkutane absorption unter verwendung von einem metalchlorid, vorzugsweise natriumchlorid, zur vorbeugung von kohäsionsschwäche
JP2008101027A (ja) * 2008-01-17 2008-05-01 Nitto Denko Corp 経皮吸収型製剤
JP2012031071A (ja) * 2010-07-28 2012-02-16 Nitto Denko Corp 貼付剤および貼付製剤
EP2551102B1 (de) * 2011-07-29 2014-12-03 3M Innovative Properties Company Selbstklebendes Schaumhaftmittel
TW202045151A (zh) 2019-02-14 2020-12-16 日商久光製藥股份有限公司 泥敷劑
JP7282701B2 (ja) * 2020-01-23 2023-05-29 久光製薬株式会社 パップ剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55131075A (en) * 1979-03-31 1980-10-11 Nitto Electric Ind Co Ltd Adhesive tape
TW201744B (de) * 1991-07-02 1993-03-11 Kanebou Textile Co Ltd
JPH0748258A (ja) * 1993-06-03 1995-02-21 Kanebo Ltd 経皮投与用製剤

Also Published As

Publication number Publication date
US6077528A (en) 2000-06-20
DE69706070T2 (de) 2002-05-02
DE69706070D1 (de) 2001-09-13
EP0965342A1 (de) 1999-12-22
JPH09315976A (ja) 1997-12-09
EP0965342A4 (de) 2000-02-09
CN1219874A (zh) 1999-06-16
EP0965342B1 (de) 2001-08-08
WO1997045121A1 (fr) 1997-12-04

Similar Documents

Publication Publication Date Title
PT783341E (pt) Dispositivo transdermal melhorado tendo deslaminagem diminuida
WO2001003917A3 (de) Wirkstoffhaltigen mehrschichtfilm aus in situ vernetzten hydrophilen polymeren
DK0922453T3 (da) Tulobuterolholdigt præparat til perkutan absorption
CA2282513A1 (en) Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
DE69706070D1 (de) Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazol
RS49609B (sr) Stabilizovani antihistaminski sirup
NO981638L (no) Legemiddel- avgivelsesanordning for to eller flere aktive forbindelser
DK1102579T3 (da) Medicinske aerosolformuleringer
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
ATE87481T1 (de) Orale arzneimittelformen von pimobendan.
DE69923348D1 (de) Transdermales arzneistoffverabreichungssystem
CA2372710A1 (en) Laminates containing an active substance for transdermal systems
DE59804823D1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
ATE98876T1 (de) Pharmazeutische praeparate.
NO954506L (no) Topiske påhelningsformuleringer inneholdende polymert materiale, glycoler og glycerider
ES2160647T3 (es) Preparacion percutanea de tulobuterol.
DK1152751T3 (da) Transdermalt, terapeutisk desoxypeganinsysstem
DK1142573T3 (da) Farmaceutiske præparater omfattende faropenem-natrium og en diaminacetatforbindelse til forbedring af absorption i mave-tarm-kanalen
BR9712078A (pt) Composto polim-rico compreendendo um ou mais lcoois ativos
ATE286732T1 (de) Azelastinhydrochlorid enthaltende zubereitung mit guter perkutaner absorptionsfähigkeit und verringerter hautreizbarkeit
DE69933671D1 (de) Adenosin a1 antagonisten gegen männliche sterilität
ATE166229T1 (de) Antitussivum
AU2002328873A1 (en) Dosage forms comprising particles containing active ingredient for application on the skin or mucous membrane
ATE316376T1 (de) Neue pharmazeutische zusammenstellung und deren herstellungsprozess
DE60008607D1 (de) Fungizide Mischung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties